Welcome to LustgartenLIVE!, our webinar series designed to bring you face-to-face with the best researchers investigating pancreatic cancer.
Moderated by Andrew Rakeman, PhD, Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations.
Hope is on the horizon!
Check back soon for details on our upcoming webinars!
Details soon to follow
Past LustgartenLive! Webinars
The ‘Global Majority’: Encouraging Recruitment of Diverse Talent in BioPharma (Monique Phillips); Health Equity and Inclusion in the Research Community + Update on their Lustgarten-Funded Research (Avery Posey, Jr., PhD and Edwin Manuel, PhD); The Genomic Basis for Disparities in Pancreatic Cancer in African American Patients and Why This Lustgarten-Funded Study Represents an Important Milestone in Cancer Research (Howard Crawford, MD); Why Increasing Diversity in Clinical Trials Benefits All Patients (Nina Garambone, MPH, CCRC)
David Tuveson, MD, PhD; Chief Scientist and Director, Lustgarten Foundation Dedicated Lab at Cold Spring Harbor Cancer Center; President, American Association of Cancer Research, Mark H. O’Hara, MD; Assistant Professor of Medicine, Hospital of the University of Pennsylvania, Eileen M. O’Reilly, MD; Winthrop Rockefeller Endowed Chair in Medical Oncology; Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Daniel A. King, MD, PhD; Director of Research and Development, Northwell Health Cancer Institute Center for Genomic Medicine, Domenech Asbun, MD; Hepatobiliary, pancreas and foregut surgeon, Miami Cancer Institute, Allyson J. Ocean, MD; Associate Professor of Clinical Medicine at Weill Cornell Medical College of Cornell University; Attending physician, New York-Presbyterian Hospital/Weill Cornell Medical Center.
- Multidisciplinary Care in Cancer Centers: Why it Matters with Katey Kennedy, 1440 Foundation; Christine A. Iacobuzio-Donahue, MD, PhD, Memorial Sloan Kettering Cancer Center; Danielle DePeralta, MD, Northwell Health Cancer Institute
- Seeing Beyond: New Horizons in Cancer Research with Nilofer Saba Azad, MD, Johns Hopkins Medicine; Jennifer J. Knox MSc, MD, FRCPC, Princess Margaret Cancer Center; Jen Jen Yeh, MD, UNC Medicine; Margaret Foti, PhD, MD, American Association of Cancer Research
- Lustgarten Foundation Career Development Award Lecture: In honor of Ruth Bader Ginsburg featuring Dannielle Engle, PhD, Salk Institute for Biological Studies
- Sharing the Journey: Fostering Growth Through Mentorship with Sommer Bazuro, PhD, FCB Health; Dannielle Engle, PhD, Salk Institute for Biological Studies; Elizabeth M. Jaffee, MD, Johns Hopkins Medicine; Jen Jen Yeh, MD, UNC Medicine; Rosalie Sears, PhD, Oregon Health & Science University; Margaret Foti, PhD, MD, American Association for Cancer Research.
The Best of 2021: Research Highlights, December 14, 2021 –Watch Lustgarten Foundation leadership for a special year-end review of the progress we’ve made toward transforming pancreatic cancer into a curable disease—and get a sneak peek into exciting research plans for 2022. Presenters include: David Tuveson, MD, PhD, Director of the Lustgarten Foundation Dedicated Research Lab at Cold Spring Harbor Laboratory (CSHL) Cancer Center; Elizabeth Jaffee, MD, Director, Lustgarten Clinical Accelerator Initiative; Linda Tantawi, CEO, Lustgarten Foundation; Andrew Rakeman, PhD VP of Research, Lustgarten Foundation. Watch now.
From the Lab to You: Clinical Advances, September 22, 2021 – World-renowned pancreatic cancer researchers and clinicians, Dr. Tyler Jacks of MIT and Dr. Brian Wolpin of the Dana-Farber Cancer Institute, explain Lustgarten’s critical role in moving research from the lab to the clinic, advancing clinical trials and better therapies. The Foundation established the Clinical Accelerator Initiative (CAI) to shorten the time from clinical trial concept to launch using a Lustgarten-developed process based on the best available science. These “smarter” clinical trials examine cutting-edge biomarkers to observe key indicators of how the treatment is working and will generate large volumes of data scientists can use now and in the future. We are funding three new clinical studies through the CAI focusing on immunotherapy to treat pancreatic cancer. Watch now.
Personalized Medicine: Transforming Treatment Wednesday, June 30, 2021 – Drs. David Tuveson, and Dennis Plenker of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Lab at CSHL, and Dr. Wasif Saif, of Northwell Health Cancer Institute, take you from the clinic to the lab to show you how personalized medicine may transform the future of pancreatic cancer treatment. Watch now.
Early Detection: The Path Forward Wednesday, April 21, 2021 – Drs. Bert Vogelstein and Elliot Fishman of the Lustgarten Foundation Dedicated Pancreatic Cancer Research Laboratory at Johns Hopkins discuss how a blood test and artificial intelligence may impact earlier detection of pancreatic cancer. Watch now.